L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3165
ETF rank
ยฃ14.12 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ10.27
Share price
0.34%
Change (1 day)
38.26%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of April 2026: 0.49%